Biomarkers and early treatment of idiopathic pulmonary fibrosis

被引：4
|
作者：
Kropski, Jonathan A. [1 ,2 ,3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA
[3] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA
来源：
LANCET RESPIRATORY MEDICINE | 2019年 / 7卷 / 09期
关键词：
PIRFENIDONE; NINTEDANIB; EFFICACY; LUNG;
D O I：
10.1016/S2213-2600(19)30256-5
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：725 / 727
页数：5
相关论文
共 50 条
  • [41] Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review
    Conal Hayton
    Dayle Terrington
    Andrew M. Wilson
    Nazia Chaudhuri
    Colm Leonard
    Stephen J. Fowler
    Respiratory Research, 20
  • [42] Biomarkers in idiopathic pulmonary fibrosis: picking the winners for trials
    Crooks, Michael G.
    Hart, Simon P.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (06): : 421 - 422
  • [43] Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
    Zhu, Weiwei
    Liu, Chunquan
    Tan, Chunting
    Zhang, Jie
    HELIYON, 2024, 10 (01)
  • [44] Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
    Bargagli, E.
    Prasse, A.
    Olivieri, C.
    Muller-Quernheim, J.
    Rottoli, P.
    PULMONARY MEDICINE, 2011, 2011
  • [45] Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis
    Kaarteenaho, Riitta
    Lappi-Blanco, Elisa
    FIBROGENESIS & TISSUE REPAIR, 2015, 8
  • [46] Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan
    Huang, Haibo
    Peng, Xiaonu
    Nakajima, Jun
    BIOSCIENCE TRENDS, 2013, 7 (04) : 172 - 177
  • [47] Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
    Njock, Makon-Sebastien
    Guiot, Julien
    Henket, Monique A.
    Nivelles, Olivier
    Thiry, Marc
    Dequiedt, Franck
    Corhay, Jean-Louis
    Louis, Renaud E.
    Struman, Ingrid
    THORAX, 2019, 74 (03) : 309 - 312
  • [48] Recognition and Treatment of Idiopathic Pulmonary Fibrosis
    Laurent P. Nicod
    Drugs, 1998, 55 : 555 - 562
  • [49] Pamrevlumab for the treatment of idiopathic pulmonary fibrosis
    Sgalla, Giacomo
    Franciosa, Claudia
    Simonetti, Jacopo
    Richeldi, Luca
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) : 771 - 777
  • [50] Nintedanib for the treatment of idiopathic pulmonary fibrosis
    Varone, Francesco
    Sgalla, Giacomo
    Iovene, Bruno
    Bruni, Teresa
    Richeldi, Luca
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (02) : 167 - 175
12345